Iridium complex, oled using the same, and nitrogen-containing tridentate ligand having carbene unit
US-2017194575-A1 · Jul 6, 2017 · US
US10008680B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10008680-B2 |
| Application number | US-201615234498-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 11, 2016 |
| Priority date | May 17, 2016 |
| Publication date | Jun 26, 2018 |
| Grant date | Jun 26, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An iridium complex and a nitrogen-containing tridentate ligand are provided. The iridium complex is represented by below formula: wherein R 1 and R 1′ are each independently substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 6 -C 12 aryl, or —C m F 2m+1 , m is an integer of 0 to 3; R 2 and R 2′ are each independently hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or unsubstituted C 6 -C 12 aryl; p and p′ are each independently 0 or 1; R 3 , R 3′ , R 4 and R 4′ are each independently hydrogen, fluorine, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 6 alkoxyl, or substituted or unsubstituted C 6 -C 12 aryl; q and q′ are each independently an integer of 0 to 3; r and r′ are each independently an integer of 0 to 4; X 1 to X 7 are each independently carbon or nitrogen; A is —O—, —CH 2 —, or —CR 2 —, R is methyl, ethyl, or propyl; and a is 0 or 1.
Opening claim text (preview).
What is claimed is: 1. An iridium complex represented by general formula (I): wherein R 1 and R 1′ are each independently substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 6 -C 12 aryl, or —C m F 2m+1 , and m is an integer of 0to 3; R 2 and R 2′ are each independently hydrogen, substituted or unsubstituted C 1 -C 12 alkyl, or substituted or unsubstituted C 6 -C 12 aryl; p and p′ are each independently 0 or 1; R 3 , R 3′ , R 4 , and R 4′ are each independently hydrogen, fluorine, substituted or unsubstituted C 1 -C 12 alkyl, substituted or unsubstituted C 1 -C 6 alkoxyl, or substituted or unsubstituted C 6 -C 12 aryl; q and q′ are each independently an integer of 0 to 3; r and r′ are each independently an integer of 0 to 4; X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , and X 7 are each independently carbon or nitrogen; A is —O—, —CH 2 —, or —CR 2 —, and R is methyl, ethyl, or propyl; a is 0 or 1; when q is equal to or greater than 2, each R 3 can be the same or different, and two or more R 3 's can joint to form a C 3 -C 8 aromatic ring; when q′ is equal to or greater than 2, each R 3′ can be the same or different, and two or more R 3′ 's can joint to form a C 3 -C 8 aromatic ring; when r is equal to or greater than 2, each R 4 can be the same or different, and two or more R 4 's can joint to form a C 3 -C 8 aromatic ring; and when r′ is equal to or greater than 2, each R 4′ can be the same or different, and two or more R 4′ 's can joint to form a C 3 -C 8 aromatic ring. 2. The iridium complex of claim 1 , wherein a bonding site of R 1′ of a left ligand is the same as a bonding site of R 1 of a right ligand, and R 1′ and R 1 have the same structure, a bonding site of R 3′ of the left ligand is the same as a bonding site of R 3 of the right ligand, and R 3′ and R 3 have the same structure, and a bonding site of R 4′ of the left ligand is the same as a bonding site of R 4 of the right ligand, and R 4′ and R 4 have the same structure. 3. The iridium complex of claim 1 , wherein a is 0. 4. The iridium complex of claim 1 , wherein the iridium complex is electrically neutral. 5. The iridium complex of claim 4 , wherein one of p and p′ is 1, and the other of p and p′ is 0. 6. The iridium complex of claim 5 , having a structure selected from one of formula (I-1) to formula (I-32) and formula (I-32-a) to formula (I-32-b): 7. The iridium complex of claim 1 , wherein the iridium complex is negatively charged. 8. The iridium complex of claim 7 , wherein p and p′ are 0. 9. The iridium complex of claim 8 , having a structure selected from one of formula (I-33) to formula (I-42): 10. The iridium complex of claim 1 , wherein the iridium complex is positively charged. 11. The iridium complex of claim 10 , wherein p and p′ are 1. 12. The iridium complex of claim 11 , having a structure selected from one of formula (I-43) to formula (I-56): 13. The iridium complex of claim 1 , wherein a is 1. 14. The iridium complex of claim 13 , wherein one of p and p′ is 1, and the other of p and p′ is 0. 15. The iridium complex of claim 14 , having a structure selected from one of formula (I-57) to formula (I-64):
containing organic luminescent materials · CPC title
Electricity · mapped topic
containing two nitrogen atoms as heteroatoms · CPC title
Electricity · mapped topic
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.